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Backgrounds: Mitral valve prolapse is a common
cardiac disease with frequent complications.
Objectives: To study the prevalence of mitral valve
prolapse in healthy Yemenis with prevalence of its
adverse sequelae.
Methods: We performed echocardiography for 1164
healthy Yemeni individuals 615 women and 549 men
(mean age ± SD 45.7 ± 10 years), classical mitral valve
prolapse was defined as a superior displacement of
mitral valve leaflets at least 2 mm, and as a maximal leaf-
lets thickness of at least 5 mm during diastasis, and non-
classic prolapse was defined as displacement of more
than 2 mm, with a maximal thickness of less than 5 mm.
Result: 74 subjects (6.3 percent) had mitral valve pro-
lapse, 40 (3.4 percent) had classic prolapse and 34 (2.9 per-
cent) had non classic prolapse. none of the subjects with
prolapse had history of heart failure, nor any had atrial
fibrillation and but one (1.3 percent) had cerebrovascular
disease, and two (2.7 percent) had syncope, as compared
with unadjusted prevalence of these findings in the sub-
ject without prolapse of 0.0, 0.0, 0.0 and 1.3 percent, respec-
tively, chest pain, dyspnea and electrocardiographic
changes frequency were similar among two groups.
Conclusion: The prevalence of mitral valve prolapse
in adult Yemenis was 6.4 percent which is similar to other
studies in different countries but with low prevalence of
adverse sequelae in compare to other studies.
http://dx.doi:10.1016/j.jsha.2013.03.009
Thyroid stimulating hormone as risk factor for cor-
onary heart disease
Essam S. Badawy, Sayed M. Abdel-Rahman, Salwa
M. Ghonium
Background: Subclinical hypothyroidism has been
associated with hypercholesterolemia and atherosclero-
sis, so screening and treatment have been advocated to
prevent cardiovascular disease.
Objectives: Clarification of cardiovascular risk of
subclinical hypothyroidism.
Patients and Methods: 300 patients were admitted
with coronary heart disease and data collected for demo-
graphic characteristics, baseline TSH and T4 levels., base-
line cardiovascular risk factors such as diabetes, blood
pressure, smoking, LDL and HDL-cholesterol serum lev-
els, baseline used drug therapy. The 300 patients were
divided into two groups; Gr.(1): 160 patients with coro-
nary heart disease and subclinical hypothyroidism. Gr.
(2) 140 patients with coronary heart disease and euthy-
roidism. Statistical correlation between coronary heart
disease events and different TSH-serum levels was fol-
lowed. Results: As regards to age, sex and FT4 serum lev-
els, there were no statistical differences. Actually, we
noticed that patients whatever with unstable angina
(50%), revascularization (21.25%), or presented with acute
myocardial infarction (15%), had TSH serum level 4.5 or
greater and less than 20 mIU/L with normal serum levels
of L-thyroxine, which undergo what is known as underac-
tive thyroid or subclinical hypothyroidism.
Conclusion: Subclinical hypothyroidism is associ-
ated with an increased risk of coronary heart disease
especially in those with higher TSH levels and signifi-
cantly elevated in adults with TSH levels of 10 mIU/L
or greater. The results of our present study may help in
refining a TSH threshold at which larger clinical benefits
of thyroxine replacement would be expected.
http://dx.doi:10.1016/j.jsha.2013.03.010
The relationship between lactate production in the
myocardium and the development of chest pain in
patients with coronary artery disease (CAD)
Hany Ahmad Mohammad Abdelwahab
Background: Silent myocardial ischemia (SMI) was
recognized as early as the beginning of the 20th century.
The consequences of silent ischemia can be grave
because lack of symptoms and lack of symptom recogni-
tion. Early detection of SMI may prevent many episodes
of sudden cardiac death annually. However, the role and
behavior of the factors determining the occurrence of
silent myocardial ischemia have not been fully
established.
Aim of the work: To detect if there is a relationship
between the level of lactate production in the myocar-
dium and the development of chest pain in patients with
coronary artery disease (CAD).
Patient and methods: This study was carried out in
cardiology and biochemistry departments, Zagazig Uni-
versity on 46 patients (38 males) with coronary artery sig-
nificant disease (>70% stenosis) including left anterior
descending artery disease. Cannulation of coronary sinus
with Amplatz left catheter was done and a pigtail catheter
was introduced into the mid LV cavity. Right atrial pacing
was done and the heart rate was increased stepwise
10 bpm/1 min until a maximum of 150 bpm or chest pain
occurs or significant S–T segment depression occurs. LV
gram for assessment of systolic function and blood sam-
ples were withdrawn from the LV and coronary sinus
before and after pacing induced ischemia and the patients
were classified into two groups according to development
of chest pain (angina group; 28 patients) during pacing
induced tachycardia or not (silent group; 18 patients).
24-h Holter ECG monitoring was done to all patients.
Results: Myocardial lactate production was signifi-
cantly very high in angina group than in silent ischemia
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